These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

779 related articles for article (PubMed ID: 2768151)

  • 21. The Effectiveness of Aripiprazole for Tics, Social Adjustment, and Parental Stress in Children and Adolescents with Tourette's Disorder.
    Wang LJ; Chou WJ; Chou MC; Gau SS
    J Child Adolesc Psychopharmacol; 2016 Jun; 26(5):442-8. PubMed ID: 27028456
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Life events and Tourette syndrome.
    Steinberg T; Shmuel-Baruch S; Horesh N; Apter A
    Compr Psychiatry; 2013 Jul; 54(5):467-73. PubMed ID: 23219489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Phase-2 Pilot Study of a Therapeutic Combination of Δ
    Bloch MH; Landeros-Weisenberger A; Johnson JA; Leckman JF
    J Neuropsychiatry Clin Neurosci; 2021; 33(4):328-336. PubMed ID: 34340527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Premonitory Urge for Tics Scale (PUTS): initial psychometric results and examination of the premonitory urge phenomenon in youths with Tic disorders.
    Woods DW; Piacentini J; Himle MB; Chang S
    J Dev Behav Pediatr; 2005 Dec; 26(6):397-403. PubMed ID: 16344654
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ondansetron treatment in Tourette's disorder: a 3-week, randomized, double-blind, placebo-controlled study.
    Toren P; Weizman A; Ratner S; Cohen D; Laor N
    J Clin Psychiatry; 2005 Apr; 66(4):499-503. PubMed ID: 15816793
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Benchmarking Treatment Response in Tourette's Disorder: A Psychometric Evaluation and Signal Detection Analysis of the Parent Tic Questionnaire.
    Ricketts EJ; McGuire JF; Chang S; Bose D; Rasch MM; Woods DW; Specht MW; Walkup JT; Scahill L; Wilhelm S; Peterson AL; Piacentini J
    Behav Ther; 2018 Jan; 49(1):46-56. PubMed ID: 29405921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Further psychometric examination of the Tourette's Disorder Scales.
    Storch EA; Merlo LJ; Lehmkuhl H; Grabill KM; Geffken GR; Goodman WK; Murphy TK
    Child Psychiatry Hum Dev; 2007 Aug; 38(2):89-98. PubMed ID: 17136450
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Deep brain stimulation of anteromedial globus pallidus interna for severe Tourette's syndrome.
    Cannon E; Silburn P; Coyne T; O'Maley K; Crawford JD; Sachdev PS
    Am J Psychiatry; 2012 Aug; 169(8):860-6. PubMed ID: 22772329
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A multicenter, randomized, double-blind, placebo-controlled study of aripiprazole in children and adolescents with Tourette's disorder.
    Yoo HK; Joung YS; Lee JS; Song DH; Lee YS; Kim JW; Kim BN; Cho SC
    J Clin Psychiatry; 2013 Aug; 74(8):e772-80. PubMed ID: 24021518
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ondansetron treatment in patients with Tourette's syndrome.
    Toren P; Laor N; Cohen DJ; Wolmer L; Weizman A
    Int Clin Psychopharmacol; 1999 Nov; 14(6):373-6. PubMed ID: 10565805
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Guanfacine treatment of comorbid attention-deficit hyperactivity disorder and Tourette's syndrome: preliminary clinical experience.
    Chappell PB; Riddle MA; Scahill L; Lynch KA; Schultz R; Arnsten A; Leckman JF; Cohen DJ
    J Am Acad Child Adolesc Psychiatry; 1995 Sep; 34(9):1140-6. PubMed ID: 7559307
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effectiveness and safety of risperidone for children and adolescents with chronic tic or tourette disorders in Korea.
    Kim BN; Lee CB; Hwang JW; Shin MS; Cho SC
    J Child Adolesc Psychopharmacol; 2005 Apr; 15(2):318-24. PubMed ID: 15910216
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of a modified comprehensive behavioral intervention for tics for children and adolescents with tourette's syndrome: A randomized controlled trial.
    Chen CW; Wang HS; Chang HJ; Hsueh CW
    J Adv Nurs; 2020 Mar; 76(3):903-915. PubMed ID: 31782167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comorbid behavioural problems in Tourette's syndrome are positively correlated with the severity of tic symptoms.
    Zhu Y; Leung KM; Liu PZ; Zhou M; Su LY
    Aust N Z J Psychiatry; 2006 Jan; 40(1):67-73. PubMed ID: 16403042
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Therapist-guided and parent-guided internet-delivered behaviour therapy for paediatric Tourette's disorder: a pilot randomised controlled trial with long-term follow-up.
    Andrén P; Aspvall K; Fernández de la Cruz L; Wiktor P; Romano S; Andersson E; Murphy T; Isomura K; Serlachius E; Mataix-Cols D
    BMJ Open; 2019 Feb; 9(2):e024685. PubMed ID: 30772854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A double-blind, placebo-controlled trial of ω-3 fatty acids in Tourette's disorder.
    Gabbay V; Babb JS; Klein RG; Panzer AM; Katz Y; Alonso CM; Petkova E; Wang J; Coffey BJ
    Pediatrics; 2012 Jun; 129(6):e1493-500. PubMed ID: 22585765
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risperidone as a treatment for Tourette's syndrome.
    Bruun RD; Budman CL
    J Clin Psychiatry; 1996 Jan; 57(1):29-31. PubMed ID: 8543544
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Systematic review of severity scales and screening instruments for tics: Critique and recommendations.
    Martino D; Pringsheim TM; Cavanna AE; Colosimo C; Hartmann A; Leckman JF; Luo S; Munchau A; Goetz CG; Stebbins GT; Martinez-Martin P;
    Mov Disord; 2017 Mar; 32(3):467-473. PubMed ID: 28071825
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of Tourette's syndrome with Delta 9-tetrahydrocannabinol (THC): a randomized crossover trial.
    Müller-Vahl KR; Schneider U; Koblenz A; Jöbges M; Kolbe H; Daldrup T; Emrich HM
    Pharmacopsychiatry; 2002 Mar; 35(2):57-61. PubMed ID: 11951146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tic-reducing effects of music in patients with Tourette's syndrome: Self-reported and objective analysis.
    Bodeck S; Lappe C; Evers S
    J Neurol Sci; 2015 May; 352(1-2):41-7. PubMed ID: 25805454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 39.